Newsroom
Sorted by: Latest
-
Phison Collaborates with Intel to Bring Larger Local AI Workloads to Intel AI PC Platforms
TAIPEI, Taiwan--(BUSINESS WIRE)--COMPUTEX — Phison Electronics (8299TT), a global leader in NAND flash controllers and storage solutions, today announced a collaboration with Intel to enable AI PCs to deploy larger, more capable AI applications locally. The collaboration combines Intel® Core™ Ultra Series 3 processors with Phison’s Pascari aiDAPTIV, a memory extension solution that unblocks memory-constrained systems to support larger Mixture-of-Experts (MoE) AI models, longer-running AI sessio...
-
世界初の'HV Opto-Semiconductor'がグローバルトップ自動車メーカー4社への量産供給を開始
韓国ソウル--(BUSINESS WIRE)--ソウル半導体は世界初となる高電圧光半導体技術が、グローバルトップ自動車メーカー4社に採用され、本格的な量産を開始したと発表した。...
-
Snowflake and Anthropic Accelerate Enterprise AI Adoption Driven by Rising Demand for Governed AI
SAN FRANCISCO--(BUSINESS WIRE)--SNOWFLAKE SUMMIT 26--Snowflake (NYSE: SNOW), the AI Data Cloud company, and Anthropic, the AI safety and research company, today announced at Snowflake Summit 26 significant momentum in their strategic partnership. Enterprises are increasingly adopting Anthropic Claude in Snowflake Cortex AI, Snowflake’s suite of AI products, driven by growing demand for governed, production-ready AI. Together, Snowflake and Anthropic are helping enterprises move from AI experime...
-
Phison Unlocks Full-Scale AI Deployment Across Industries
TAIPEI, Taiwan--(BUSINESS WIRE)--Phison Electronics (8299TT), a global leader in NAND flash controllers and storage solutions, today announced a new strategic initiative at COMPUTEX 2026 under the theme “AI Enabler: Evolving Data Storage Intelligence.” Expanding beyond its role as a storage technology leader, Phison is taking a systems-level approach to AI solutions spanning AI infrastructure, edge AI computing and AI software platforms. At COMPUTEX 2026, Phison is showcasing comprehensive AI s...
-
PHR INVESTOR ALERT: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of Phreesia, Inc. Investors
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE:PHR) investors of the July 13, 2026 lead plaintiff deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Phreesia securities between May 8, 2025 through March 30, 2026 (“the Class Period”).Courts do not consider applications filed after the lead plaintiff deadline. The lead plaintiff oversees the litigation on behalf of the...
-
France Signs Historic Two-Mission Agreement with Vast to the International Space Station and Haven-1, Scheduled to be the World’s First Commercial Space Station
PARIS--(BUSINESS WIRE)--Today at the Choose France Summit, created by the President of the French Republic, Emmanuel Macron, Vast announced its commitment to establish its European headquarters in Paris and an agreement with the Government of France, for two missions involving two French astronauts: the sixth private astronaut mission to the International Space Station and the Haven-1 test flight, the first crewed mission to Vast’s Haven-1 commercial space station scheduled to launch in 2027. F...
-
INVESTOR ALERT: Securities Class Action Filed Against Lucid Group, Inc. – Investors Encouraged to Contact Kirby McInerney LLP
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Lucid Group, Inc. (“Lucid” or the “Company”) (NASDAQ:LCID) securities during the period of February 25, 2026 through April 13, 2026, inclusive (“the Class Period”).If you suffered a loss on your Lucid investments, you have until July 28, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitted after...
-
Fulgent Presents Updated FID-007 Data at ASCO 2026
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with established laboratory services and therapeutic development businesses, today announced it presented updated data in the Head and Neck Cancer Track during the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting Rapid Oral Abstract Session, scheduled from 4:30 p.m. to 6:00 p.m. CDT in Hall D1 at McCormick Place in Chicago. The abstract, entitled “FID...
-
Ono Pharma Announces Oral Presentation of New Data from the Phase 2 Clinical Study of ONO-4578 (EP4 antagonist) in Certain Gastric Cancers at the ASCO 2026 Annual Meeting
OSAKA, Japan--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”) today announced the results of the phase 2 clinical study (ONO-4578-08 study) of the EP4 antagonist ONO-4578 in patients with previously untreated, HER2-negative unresectable advanced or recurrent gastric cancer (including gastroesophageal junction cancer). The results were presented at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting. In this stu...
-
RSA Extends Passwordless Leadership to Linux at Authenticate APAC 2026
SINGAPORE--(BUSINESS WIRE)--RSA, the security-first identity leader, today announced new passwordless authentication support for Linux environments, marking another milestone in the company's ongoing mission to deliver passwordless access to every user, in every environment, every time. The announcement was made at Authenticate APAC 2026, taking place June 2–3 at Marina Bay Sands in Singapore. Linux is ubiquitous in enterprise infrastructure—powering servers, developer workstations, and critica...